Advisory Services Network’s Lifecore Biomedical LFCR Stock Holding History

Advisory Services Network’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,677	Closed	-$16.6K	–	2696
2023 Q4	$16.6K	Buy	+2,677	New	+$18.6K	﹤0.01%	2624
2016 Q3	$19K	Hold	1,425	–	–	﹤0.01%	1137
2016 Q2	$15K	Hold	1,425	–	–	﹤0.01%	1090
2016 Q1	$15K	Hold	1,425	–	–	﹤0.01%	973
2015 Q4	$17K	Hold	1,425	–	–	0.01%	830
2015 Q3	$17K	Hold	1,425	–	–	0.01%	783
2015 Q2	$21K	Hold	1,425	–	–	0.01%	718
2015 Q1	$21K	Hold	1,425	–	–	0.01%	674
2014 Q4	$19K	Buy	+1,425	New	+$18.4K	0.01%	599
2014 Q1	–	Sell	-50	Closed	-$1K	–	541
2013 Q4	$1K	Buy	+50	New	+$597	﹤0.01%	1049

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisory Services Network's LFCR Position: Q1 2024 in Review

Advisory Services Network sold out of Lifecore Biomedical (LFCR) in Q1 2024, closing a stake of 2,677 shares — an estimated $16.6K sold.

Advisory Services Network first reported a position in LFCR in Q4 2013 and held it in 10 quarters. The position peaked at $21K in Q2 2015. 79 funds tracked by Wall St. Rank hold LFCR as of Q1 2024.

Advisory Services Network reported no remaining Lifecore Biomedical position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 2,677 Lifecore Biomedical shares in Q1 2024, an estimated $16.6K.
Advisory Services Network first reported a position in Lifecore Biomedical in Q4 2013 and held it in 10 quarters.
Advisory Services Network's Lifecore Biomedical position peaked at $21K in Q2 2015.
79 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.